Genomic Valley Biotech Ltd — Board Meeting, 07-08-2025: Board Meeting

Genomic Valley Biotech's board approved the financial results for the quarter ended June 30, 2025, reporting a profit of 0.02 Cr. The company appointed M/s. SBR & Co. LLP as Secretarial Auditors for FY25-30 and Mr. Navjyoti Kumar Jha as Internal Auditor for FY25-26. The board also re-appointed Mr. Yogesh Agrawal as Chairman & Managing Director for a five-year term starting September 7, 2025. He is a promoter with a shareholding of 14.27 lakh equity shares and drew a remuneration of 0.02 Cr last year. These decisions strengthen governance and leadership.